2010/12/16

Bellacehol

Release form, composition and packing Bellacehol 

Tablets, coated yellow, biconvex forms. 1 tab. amount of alkaloids belladonna 150 mcg tanatsehol (with a total flavonoid and phenol carbonic acids in terms of lutein and dry matter 50%) 50 mg. Excipients: lactose, potato starch, calcium stearate, Aerosil A-380. The composition of the shell: sugar, gelatin, Aerosil A-380, Magnesium Hydroxide, Titanium Dioxide, tropeolin-On.

Clinico-pharmacological group: drug with choleretic and spasmolytic effect.

Pharmacological action

Combined medication. Possesses antiulcer action due to vagal blockade on gastric secretion, antispasmodic, analgesic, and reparative action. Normalizes the functional activity of the liver, stimulates bile secretion, and improves the biochemical composition of bile.

Pharmacokinetics

Data on the pharmacokinetics Bellatsehol not given.

Statement

In the combined therapy:
exacerbation of chronic gastritis and / or gastroduodenitis (incl. zrozivno-ulcerative changes);
gastric ulcer and duodenal ulcer, combined with chronic cholecystitis, gipomotornoy biliary dyskinesia.

Dosing regimen

Oral, 1 tab. 3 times / day for 20-30 minutes before eating. In case of need, and with good endurance can increase the daily dose of 6 tab.

Length is determined by your doctor, individually and as a rule, is 3-4 weeks.

Side effect

Maybe: allergic reactions, dry mouth. When used in high doses: accommodation disturbance, difficulty urinating.

Contraindications
glaucoma;
prostate adenoma;
tachyarrhythmia;
hyperthyroidism;
heart failure;
pyloric stenosis;
cholelithiasis;
pregnancy;
Lactation (breastfeeding);
childhood and adolescence to 18 years;
hypersensitivity to the drug.

Overdose

Symptoms: dry mouth, thirst, constipation, feeling of palpitation, mydriasis, transient blurred vision, photophobia, redness of skin, intestinal atony, urinary retention, headache, dizziness, fever, and in rare cases - psychomotor agitation, convulsions.

Treatment: gastric lavage, symptomatic therapy.

Drug Interactions

Reduces the effect of m-holinomimetikov and anticholinesterase drugs.

Conditions and terms of

List B. The drug should be kept away from children, dry, dark place at temperatures not above 25 ° C. Shelf life - 2 years.